Literature DB >> 25287683

Osteoarthritis: Animal data show VEGF blocker inhibits post-traumatic OA.

Caroline Barranco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25287683     DOI: 10.1038/nrrheum.2014.173

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis.

Authors:  Toshihiro Nagai; Masato Sato; Miyuki Kobayashi; Munetaka Yokoyama; Yoshiki Tani; Joji Mochida
Journal:  Arthritis Res Ther       Date:  2014-09-18       Impact factor: 5.156

  1 in total
  5 in total

1.  Inhibition of vascular endothelial growth factor with shRNA in chondrocytes ameliorates osteoarthritis.

Authors:  Xufang Zhang; Ross Crawford; Yin Xiao
Journal:  J Mol Med (Berl)       Date:  2016-05-10       Impact factor: 4.599

Review 2.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

3.  TGF-β1 regulates chondrocyte proliferation and extracellular matrix synthesis via circPhf21a-Vegfa axis in osteoarthritis.

Authors:  Shiyuan Lin; Huizi Li; Biao Wu; Jie Shang; Ning Jiang; Rong Peng; Baizhou Xing; Xianghe Xu; Huading Lu
Journal:  Cell Commun Signal       Date:  2022-05-30       Impact factor: 7.525

Review 4.  Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis.

Authors:  Pratiek N Matkar; Ramya Ariyagunarajah; Howard Leong-Poi; Krishna K Singh
Journal:  Biomolecules       Date:  2017-10-02

Review 5.  Subchondral bone microenvironment in osteoarthritis and pain.

Authors:  Yan Hu; Xiao Chen; Sicheng Wang; Yingying Jing; Jiacan Su
Journal:  Bone Res       Date:  2021-03-17       Impact factor: 13.567

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.